Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Dynavax initiates two new phase II/III trials for ragweed allergy treatment

May 24, 2001

ID Biomedical begins clinical evaluation of intranasal influenza vaccine

May 24, 2001

Bimosiamose blocks kidney allograft rejection and is synergistic with other agents

May 24, 2001

Prostanoid receptor agonist protects against warm ischemia-reperfusion injury in rat kidneys

May 24, 2001

Safety and efficacy of ISIS-2302 in preventing acute renal allograft rejection

May 23, 2001

Transplant 2001: RARalpha agonists as candidates for allograft rejection

May 23, 2001

Nabi begins trial to evaluate booster dose of Nabi StaphVAX in immunocompromised patients

May 21, 2001

New compounds designed by AstraZeneca useful in cases of excess apoptosis

May 18, 2001

Naturally occurring octadecapeptide possesses immunomodulatory properties

May 18, 2001

First combination hepatitis A & B vaccine approved by FDA

May 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...